Roy D. Baynes Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Roy D. Baynes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Roy D. Baynes. Roy D. Baynes is a Director in Retrophin, Inc. ($RTRX) and a in Atara Biotherapeutics, Inc. ($ATRA) and a Director in Atara Biotherapeutics, Inc. ($ATRA) and a Director in Natera, Inc. ($NTRA).
Address: C/O RETROPHIN, INC. 12255 EL CAMINO REAL, STE 250 SAN DIEGO 92130 CA
Companies in which Roy D. Baynes is an Insider
Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Roy D. Baynes:
Holdings: 23,000 shares
Current Value: $346,150
Latest Transaction: Jun 09 2021
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Natera, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Roy D. Baynes: Director
Holdings: 1,300 shares
Current Value: $11,895
Latest Transaction: Aug 11 2020
$NTRA Market Capitalization: $481.39M
$NTRA Previous Close: $9.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roy D. Baynes: Director
Holdings: 14,000 shares
Current Value: $280,980
Latest Transaction: May 19 2020
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Roy D. Baynes
Sentiment: All, ATRA, NTRA, RTRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | M | 24.42 | 1,300 | 31,746 | 15,230 | |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Sell | S | 53.47 | 1,300 | 69,513 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Buy | M | 24.42 | 1,300 | 31,746 | 1,300 | 0 to 1.3 K |